Federated Hermes’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$763K Sell
8,856
-103
-1% -$9.24K ﹤0.01% 1189
2025
Q4
$782K Sell
8,959
-2,726
-23% -$207K ﹤0.01% 1194
2025
Q3
$669K Sell
11,685
-582
-5% -$33.5K ﹤0.01% 1267
2025
Q2
$724K Sell
12,267
-361
-3% -$23.3K ﹤0.01% 1235
2025
Q1
$924K Buy
12,628
+1,893
+18% +$156K ﹤0.01% 1127
2024
Q4
$888K Sell
10,735
-537
-5% -$42.4K ﹤0.01% 1141
2024
Q3
$806K Sell
11,272
-165
-1% -$11.6K ﹤0.01% 1193
2024
Q2
$783K Sell
11,437
-1,863
-14% -$111K ﹤0.01% 1190
2024
Q1
$713K Sell
13,300
-1,087
-8% -$58.4K ﹤0.01% 1244
2023
Q4
$767K Sell
14,387
-2,467
-15% -$120K ﹤0.01% 1227
2023
Q3
$837K Buy
16,854
+8,319
+97% +$465K ﹤0.01% 1177
2023
Q2
$508K Sell
8,535
-2,955
-26% -$168K ﹤0.01% 1367
2023
Q1
$651K Buy
11,490
+501
+5% +$32.1K ﹤0.01% 1323
2022
Q4
$816K Sell
10,989
-1,415
-11% -$96.3K ﹤0.01% 1209
2022
Q3
$739K Sell
12,404
-657
-5% -$39.6K ﹤0.01% 1219
2022
Q2
$733K Sell
13,061
-3,772
-22% -$248K ﹤0.01% 1259
2022
Q1
$1.24M Sell
16,833
-431
-2% -$30K ﹤0.01% 1176
2021
Q4
$1.25M Buy
17,264
+200
+1% +$14.5K ﹤0.01% 1202
2021
Q3
$1.31M Buy
17,064
+2,988
+21% +$240K ﹤0.01% 1184
2021
Q2
$1.09M Sell
14,076
-1,592
-10% -$113K ﹤0.01% 1291
2021
Q1
$966K Sell
15,668
-45,380
-74% -$2.87M ﹤0.01% 1394
2020
Q4
$3.98M Sell
61,048
-542
-0.9% -$31.2K 0.01% 870
2020
Q3
$3.05M Sell
61,590
-8,637
-12% -$445K 0.01% 860
2020
Q2
$3.35M Sell
70,227
-113,787
-62% -$5.49M 0.01% 818
2020
Q1
$7.83M Sell
184,014
-28,774
-14% -$1.42M 0.02% 533
2019
Q4
$12.5M Buy
212,788
+109,422
+106% +$5.94M 0.03% 546
2019
Q3
$5.28M Sell
103,366
-44,025
-30% -$2.1M 0.01% 764
2019
Q2
$6.24M Sell
147,391
-29,929
-17% -$1.3M 0.02% 717
2019
Q1
$8.76M Sell
177,320
-73,361
-29% -$3.32M 0.02% 616
2018
Q4
$10.8M Sell
250,681
-41,102
-14% -$2.05M 0.03% 462
2018
Q3
$16.6M Sell
291,783
-38,350
-12% -$2.02M 0.04% 401
2018
Q2
$16.7M Buy
330,133
+129,368
+64% +$6.75M 0.05% 299
2018
Q1
$10M Buy
200,765
+172,620
+613% +$8.11M 0.03% 423
2017
Q4
$1.16M Sell
28,145
-5,544
-16% -$194K ﹤0.01% 1173
2017
Q3
$1M Buy
33,689
+884
+3% +$27K ﹤0.01% 1197
2017
Q2
$1.09M Sell
32,805
-7,473
-19% -$235K ﹤0.01% 1167
2017
Q1
$1.19M Sell
40,278
-15,787
-28% -$431K ﹤0.01% 1119
2016
Q4
$1.39M Buy
+56,065
New +$1.27M ﹤0.01% 1017
2016
Q2
Sell
-6,488
Closed -$154K 2121
2016
Q1
$154K Buy
6,488
+243
+4% +$5.94K ﹤0.01% 1518
2015
Q4
$174K Sell
6,245
-2,696
-30% -$67.7K ﹤0.01% 1495
2015
Q3
$185K Buy
+8,941
New +$226K ﹤0.01% 1513

Other funds holding GMED

Federated Hermes's GMED Position: Q1 2026 in Review

Federated Hermes reduced its Globus Medical (GMED) stake by 1.1% in Q1 2026, selling an estimated $9.24K and leaving 8,856 shares worth $763K. The position accounts for ﹤0.01% of the portfolio, ranked #1189.

Federated Hermes first reported a position in GMED in Q3 2015 and has held it in 41 quarters since. The position peaked at $16.7M in Q2 2018. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Federated Hermes held 8,856 shares of Globus Medical worth $763K as of Q1 2026.
  • Federated Hermes sold 103 Globus Medical shares in Q1 2026, an estimated $9.24K.
  • Globus Medical made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1189 holding.
  • Federated Hermes first reported a position in Globus Medical in Q3 2015 and has held it in 41 quarters since.
  • Federated Hermes's Globus Medical position peaked at $16.7M in Q2 2018.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.